U.S. Government Agency Makes Cancer Treatment Inhibitors Available for Licensing

Summary

The U.S. Government agency responsible for the invention, Mutant IHD1 Inhibitors Useful for Treating Cancer, is now open to licensing and/or co-development opportunities in the U.S.